Antiviral resistance and impact on viral replication capacity: evolution of viruses under antiviral pressure occurs in three phases.
about
Factors shaping the adaptive landscape for arboviruses: implications for the emergence of diseaseViral quasispecies evolutionCounteracting Quasispecies Adaptability: Extinction of a Ribavirin-Resistant Virus Mutant by an Alternative Mutagenic TreatmentIs Single-Strand Conformation Polymorphism Analysis of the Full 5' Untranslated Region an Adequate Approach To Study Hepatitis C Virus Quasispecies Distribution?Targeting the Brain Reservoirs: Toward an HIV CurePotential benefits of sequential inhibitor-mutagen treatments of RNA virus infectionsOnly slight impact of predicted replicative capacity for therapy response predictionHsp90 inhibitors exhibit resistance-free antiviral activity against respiratory syncytial virusUpdate on influenza diagnostics: lessons from the novel H1N1 influenza A pandemicSequential adaptive mutations enhance efficient vector switching by Chikungunya virus and its epidemic emergence.Persistence of frequently transmitted drug-resistant HIV-1 variants can be explained by high viral replication capacity.Anti-HIV-1 activity of flavonoid myricetin on HIV-1 infection in a dual-chamber in vitro model.New strategies for the treatment of hepatitis C virus infection and implications of resistance to new direct-acting antiviral agentsTempo and mode of inhibitor-mutagen antiviral therapies: a multidisciplinary approach.Characterization of the Drug Resistance Profiles of Patients Infected with CRF07_BC Using Phenotypic Assay and Ultra-Deep Pyrosequencing.Molecular and Genetic Characterization of HIV-1 Tat Exon-1 Gene from Cameroon Shows Conserved Tat HLA-Binding Epitopes: Functional Implications.Genotyping and Mutation Pattern in the Overlapping MHR Region of HBV Isolates in Southern Khorasan, Eastern Iran.Molecular control of HIV-1 postintegration latency: implications for the development of new therapeutic strategies.HCV drug discovery aimed at viral eradication.Mechanisms of viral emergence.Future treatment of chronic hepatitis C with direct acting antivirals: is resistance important?Achieving a cure for HIV infection: do we have reasons to be optimistic?The paramyxovirus polymerase complex as a target for next-generation anti-paramyxovirus therapeutics.Evolutionary consequences of drug resistance: shared principles across diverse targets and organisms.Improving combination antiretroviral therapy by targeting HIV-1 gene transcription.Ribavirin can be mutagenic for arenaviruses.Predictive value of HIV-1 replication capacity and phenotypic susceptibility scores in antiretroviral treatment-experienced patients.The Quest for Materials-Based Hydrogels with Antimicrobial and Antiviral Potentialities
P2860
Q24273397-F0AB6301-8FB3-4BD0-AAD9-BA1330ECDFF5Q27013917-24E3022F-B5EC-4680-B161-86FF6DEA6403Q27488361-6E47CCB8-217B-4AD8-AAE1-4013BABFBE61Q27489519-ACC057D2-67C5-475C-A9B5-3D71AEBE202AQ28075694-EAA38323-17F3-4A38-98C5-84AEED3816CDQ28471847-B87FB2AC-AEF7-4A4E-83D0-C9F1DED635EDQ28472749-A7C3D70F-39F7-4038-A7F0-29407B1C2738Q28486995-5FB35FD1-7D9A-47E4-B001-8C9359627815Q30415228-0EB47D01-7645-40B6-9EE3-C4BFD7D4B76AQ34102716-CA0407C2-E125-47A4-A834-B1470C51C86FQ34677368-AA2FF5AC-E67F-4319-98E6-A953E132990BQ34784838-FC37EAA8-D511-4CE1-9DD3-C27C718927E6Q35026553-68ACAAEC-68E2-4D02-95D3-DAD27EBC1D4EQ35229409-5371D9FE-DBF3-48EF-9B5E-66E90825CA48Q36255602-7AB1D6E8-E1F9-4FB6-A836-7FE2581F715EQ37153763-260B934A-19CB-46C0-8B30-A8D894CB4392Q37417336-D4589A71-1556-46D9-9BC3-2B2D05B697A3Q37644561-7EB1DEAA-E65B-4C68-AFF2-3883BB6322F5Q37664059-00AA06B4-CAE0-4D8D-BC3D-A96A53A7B743Q37694793-753C491E-25A3-4B8A-908F-64E4F49E994FQ37972767-F7C0731E-AA79-4159-8FBC-4B8F1CBCFFE4Q37980423-5F4B143F-9911-4094-8CB5-E84EC75283C4Q38510112-BAD074A5-205F-4B04-A678-7F6254364CB5Q38543385-00EBB885-6714-451D-9555-A6AA7FEBF013Q38856263-8C93B4DC-B6A0-444A-A60F-60B620F054C2Q39544616-0265F962-A2EB-4755-8E79-F4F025D627BCQ48745542-00C562C7-810A-46C6-8F55-A4211E4814B9Q57131047-8E2A71FF-C77A-425E-B1D3-05B825473FB6
P2860
Antiviral resistance and impact on viral replication capacity: evolution of viruses under antiviral pressure occurs in three phases.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Antiviral resistance and impac ...... essure occurs in three phases.
@ast
Antiviral resistance and impac ...... essure occurs in three phases.
@en
Antiviral resistance and impac ...... essure occurs in three phases.
@nl
type
label
Antiviral resistance and impac ...... essure occurs in three phases.
@ast
Antiviral resistance and impac ...... essure occurs in three phases.
@en
Antiviral resistance and impac ...... essure occurs in three phases.
@nl
prefLabel
Antiviral resistance and impac ...... essure occurs in three phases.
@ast
Antiviral resistance and impac ...... essure occurs in three phases.
@en
Antiviral resistance and impac ...... essure occurs in three phases.
@nl
P2093
P1476
Antiviral resistance and impac ...... essure occurs in three phases.
@en
P2093
C A B Boucher
N M van Maarseveen
P304
P356
10.1007/978-3-540-79086-0_11
P577
2009-01-01T00:00:00Z